51成人动漫

Oncology/Hematology >

Breast Cancer

News, opinions and meeting coverage in oncology/hematology.

Device May Cut Re-Excision Rate in Breast Cancer

SAN FRANCISCO -- Re-excision after breast-conserving surgery occurred 50% less often with intraoperative margin assessment by a device that distinguishes cancer cells from normal tissue, results of a randomized study showed.

Lying Prone for Radiation Best for Breast Tx

Lying face down for radiation therapy lessens the amount of collateral damage to breast cancer patients' heart and lungs, researchers found.

Doctors Say 45 Common Tests 'Overused'

Nine specialty groups have listed tests and treatments that are frequently overused, such as antibiotics for sinus attacks and CT scans for low back pain, in the first phase of a long-term project.

Komen Official Quits After Controversy

A vice-president at the Susan G. Komen for the Cure Foundation has resigned in the wake of the controversy surrounding the organization's decision -- since reversed -- to stop funding Planned Parenthood's breast cancer programs.

FDA Revokes Avastin Approval for Breast Cancer

WASHINGTON -- The FDA has announced that bevacizumab (Avastin) is no longer approved for the treatment of breast cancer; the Genentech drug retains its other indications and will remain on the market.

AMA Adopts Policies on Circumcision, Gun Safety

The American Medical Association (AMA) House of Delegates has adopted a number of new policies at its interim meeting, including policies on male circumcision, physician discussion of gun safety, and a new medical coding system that will go into effect in 2013.

MBCS: Lumpectomy 'Safe' for Young Breast Cancer Patients

SAN FRANCISCO -- Lumpectomy doesn't carry higher recurrence or mortality risk than mastectomy for young women with breast cancer, two separate studies found.

Medicare to Keep Paying for Avastin

WASHINGTON -- Medicare will continue to pay for bevacizumab (Avastin) when it's used to treat metastatic breast cancer, even if the FDA decides to remove that indication from the drug, a spokesman for the Centers for Medicare and Medicaid Services (CMS) said.

ASCO: Flaxseed No Help for Hot Flashes

CHICAGO -- Flaxseed will not ease hot flashes for women with menopausal symptoms or breast cancer survivors taking anti-estrogen drugs, according to clinical trial results.

ASCO Breast: Gamma Imaging Tops Breast Ultrasound

NATIONAL HARBOR, Md. -- Breast-specific gamma imaging (BSGI) outperformed breast ultrasound for evaluating patients with indeterminate mammograms in a retrospective comparison of the two imaging techniques, researchers reported here.

ASCO: Survival No Better After Axillary Node Surgery

CHICAGO -- Routine removal of axillary nodes in breast cancer patients with lymph node involvement does not improve survival or lessen the risk of relapse, a researcher said here.

ASCO: Value of RT After Lumpectomy Questioned

CHICAGO -- Postlumpectomy radiation therapy had minimal impact on outcomes in older patients with early-stage breast cancer, data from a larger intergroup trial showed.

ASCO: Cancer Survivors Get Benefit from Yoga

CHICAGO -- Gentle stretching, breathing, and other exercises in a regular yoga program may ease sleep and fatigue problems common among cancer survivors, a randomized trial found.

The Top 10 Medical Advances of the Decade

From genome to hormones, doctors pick the top medical advances of the decade.

ASCO Breast: Even 'Tweens Fear Breast Cancer

SAN FRANCISCO -- Fear about breast cancer starts early, as girls see it affect those close to them and hear reports in the media, researchers found.

ASCO: Bevacizumab (Avastin) May Reduce Progression in Advanced Breast Cancer

CHICAGO -- In recurrent or metastatic breast cancer, bevacizumab (Avastin) significantly improved progression-free survival when added to docetaxel (Taxotere), a multicenter European study showed.

SABCS: Testosterone Relieves Atrophic Vaginitis in Breast Cancer Patients

SAN ANTONIO -- Intravaginal testosterone may offer relief from atrophic vaginitis without the risks of estrogen to breast cancer patients taking aromatase inhibitors, according to a pilot study.

ASPS: Obese Women Have More Breast Reconstruction Complications

SAN FRANCISCO -- Breast reconstruction surgery in extremely obese women is associated with a high rate of complications, reported researchers here.

ASCO: Five Years of Arimidex Causes Bone Loss

ATLANTA 芒鈧€� Five years of breast cancer adjuvant therapy with an aromatase inhibitor, can lead to a 6% to 7% loss of bone mineral density, a trigger for osteoporosis for women who are borderline osteopenic when they begin treatment, investigators reported here.

Estrogen Alone Does Not Increase Risk of Breast Cancer

STANFORD, Calif. - Post-menopausal women who took estrogen alone for more than seven years did not have an increased risk of breast cancer, according to a study of more than 10,000 women ages 50 to 79. The data were dramatically different from a sister study stopped in 2002 of estrogen plus progestin.